Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Receivables (2018 - 2026)

AdaptHealth has reported Receivables over the past 8 years, most recently at $415.6 million for Q4 2025.

  • For Q4 2025, Receivables fell 7.57% year-over-year to $415.6 million; the TTM value through Dec 2025 reached $415.6 million, down 7.57%, while the annual FY2025 figure was $415.6 million, 7.57% down from the prior year.
  • Receivables for Q4 2025 was $415.6 million at AdaptHealth, up from $412.5 million in the prior quarter.
  • Over five years, Receivables peaked at $477.3 million in Q2 2024 and troughed at $274.6 million in Q1 2021.
  • A 5-year average of $404.1 million and a median of $407.8 million in 2023 define the central range for Receivables.
  • Biggest five-year swings in Receivables: skyrocketed 135.53% in 2021 and later dropped 10.58% in 2025.
  • Year by year, Receivables stood at $383.7 million in 2021, then grew by 3.66% to $397.7 million in 2022, then rose by 14.98% to $457.3 million in 2023, then decreased by 1.68% to $449.6 million in 2024, then dropped by 7.57% to $415.6 million in 2025.
  • Business Quant data shows Receivables for AHCO at $415.6 million in Q4 2025, $412.5 million in Q3 2025, and $426.8 million in Q2 2025.